2 Key Reasons Morgan Stanley Upgraded Alexion Pharmaceuticals By: Benzinga via Benzinga May 25, 2017 at 10:38 AM EDT Analysts at Morgan Stanley upgraded Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) Thursday despite the stock's 17-percent loss year to ... Read More >> Related Stocks: Alexion Pharmaceuticals